Acorah Software Products - Accounts Production 19.2.450 false true 31 January 2025 1 February 2024 false 1 February 2025 31 January 2026 31 January 2026 07903219 Mr Paul Matthews iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07903219 2025-01-31 07903219 2026-01-31 07903219 2025-02-01 2026-01-31 07903219 frs-core:ShareCapital 2026-01-31 07903219 frs-core:RetainedEarningsAccumulatedLosses 2026-01-31 07903219 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 07903219 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 07903219 frs-bus:SmallEntities 2025-02-01 2026-01-31 07903219 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 07903219 frs-bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 07903219 frs-bus:Director1 2025-02-01 2026-01-31 07903219 frs-countries:EnglandWales 2025-02-01 2026-01-31 07903219 2024-01-31 07903219 2025-01-31 07903219 2024-02-01 2025-01-31 07903219 frs-core:ShareCapital 2025-01-31 07903219 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31
Registered number: 07903219
Mfx Bio Tech Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2026
Bradbury Stell Ltd
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 07903219
2026 2025
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 538,327 586,135
Cash at bank and in hand 245 304
538,572 586,439
Creditors: Amounts Falling Due Within One Year 5 (465,643 ) (463,385 )
NET CURRENT ASSETS (LIABILITIES) 72,929 123,054
TOTAL ASSETS LESS CURRENT LIABILITIES 72,929 123,054
NET ASSETS 72,929 123,054
CAPITAL AND RESERVES
Called up share capital 6 100 100
Profit and Loss Account 72,829 122,954
SHAREHOLDERS' FUNDS 72,929 123,054
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Paul Matthews
Director
30/10/2026
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Mfx Bio Tech Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 07903219 . The registered office is Unit 2 Beverley Court 26, Elmtree Road, Teddington, TW11 8ST .
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
4. Debtors
2026 2025
£ £
Due within one year
Other debtors 538,327 586,135
5. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Other creditors 465,643 463,385
6. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 100 100
Page 2